Plant-Based Smoking Cessation Alternative Cytisine ‘Likely’ To Help Quitters
Executive Summary
“Moderate-certainty evidence” shows that low-cost smoking cessation therapy cytisine “probably” helps more people to quit smoking than a placebo and “low-certainty evidence” suggests that the natural alternative may also help more people to quit than using a nicotine replacement monotherapy, finds a recently published Cochrane Review.
You may also be interested in...
Why Did Germany Reject OTC Switch Of Low-Cost Smoking Cessation Drug Cytisine?
At its first meeting of 2023, Germany's switch committee voted against switching to OTC status low-cost smoking cessation drug cytisine. Complex treatment guidelines and concerns about side effects were among the considerations leading to this decision, the recently published minutes show.
EFSA Considering New CBD Toxicity Data While Clock-Stop Causes Industry ‘Economic Harm’
The European Food Safety Authority is evaluating new reproductive and developmental toxicity data published since it paused CBD novel food applications last year due to safety concerns, according to food law consultancy, Legal Foods.
German OTC Launches: Bayer Adds Probiotics, Angelini Expands ThermaCare, And More
Two microbiome products added to Bayer's Iberogast line, a new drug-free pain-relieving ThermaCare knee brace from Angelini Pharma and an ashwagandha-powered sleep aid extension to Oyono from Klosterfrau feature in this German marketing update.